CZC-54252 is primarily used in research settings as a selective inhibitor targeting specific biological pathways, particularly TBK1 and IKKε kinases. It is often employed in biochemical studies to investigate the mechanisms of certain enzymes or proteins, helping scientists understand their roles in cellular processes such as innate immune responses. This compound is particularly valuable in drug discovery and development, where it serves as a tool to explore potential therapeutic targets for diseases such as cancer or inflammatory disorders. Its application in laboratory experiments aids in identifying new treatment strategies by modulating specific molecular interactions.